Cardinal Health (CAH) Misses Q4 EPS by 43c, FY22 EPS Outlook Misses Consensus
Tweet
Share
E-mail
Get Alerts CAH Hot Sheet
Price: $247.18 -0.58%
EPS Growth %: +15.3%
Financial Fact:
Distribution, selling, general and administrative expenses: 920M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +15.3%
Financial Fact:
Distribution, selling, general and administrative expenses: 920M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cardinal Health (NYSE: CAH) reported Q4 EPS of $0.77, $0.43 worse than the analyst estimate of $1.20. Revenue for the quarter came in at $42.59 billion versus the consensus estimate of $40.39 billion.
GUIDANCE:
Cardinal Health sees FY2022 EPS of $5.60-$5.90, versus the consensus of $6.19.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
